UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Hyperpolarized MRI Visualizes Warburg Effects and Predicts Treatment Response to mTOR Inhibitors in Patient-Derived ccRCC Xenograft Models

Cancer research (Chicago, Ill.), 2019-01, Vol.79 (1), p.242-250

2019

Volltextzugriff (PDF)

MYC Phosphorylation at Novel Regulatory Regions Suppresses Transforming Activity

Cancer research (Chicago, Ill.), 2013-11, Vol.73 (21), p.6504-6515

2013

Volltextzugriff (PDF)

Abstract CT055: Phase 1/2 primary analysis of ZUMA-6: Axicabtagene ciloleucel (Axi-Cel) in combination With atezolizumab (Atezo) for the treatment of patients (Pts) with refractory diffuse large B cell lymphoma (DLBCL)

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT055-CT055

2020

Volltextzugriff (PDF)

The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts

Cancer research (Chicago, Ill.), 1999-09, Vol.59 (17), p.4200-4203

1999

Volltextzugriff (PDF)

Abstract 6339: BCA101, a novel tumor-targeted bifunctional fusion antibody simultaneously inhibiting EGFR and TGF-β signaling with potential for durable tumor growth inhibition

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.6339-6339

2023

Volltextzugriff (PDF)

Abstract LB-288: Differential cohort effect on early- and late-onset breast cancer incidence among Chinese women in different populations

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.LB-288-LB-288

2014

Volltextzugriff (PDF)

Abstract LB-117: Myc phosphorylation suppresses transformation through novel regulatory regions

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.LB-117-LB-117

2013

Volltextzugriff (PDF)

Abstract 4926: Modeling the transcriptome landscape of HER2+ breast cancer

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.4926-4926

2012

Volltextzugriff (PDF)

Abstract 4975: Next generation sequencing reveals a connection between KRAS mutation and the NFkB pathway in lung adenocarcinoma samples

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4975-4975

2011

Volltextzugriff (PDF)

Abstract 3184: Whole genome sequencing of low-input fresh frozen prostate cancer biopsies

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.3184-3184

2012

Volltextzugriff (PDF)

Abstract 2003: A molecular portrait of potentially curable prostate cancer

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.2003-2003

2013

Volltextzugriff (PDF)

Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion

Cancer research (Chicago, Ill.), 1990, Vol.50 (1), p.197-201

1990

Volltextzugriff (PDF)

Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes : possible relevance to fluoropyrimidine chemotherapy

Cancer research (Chicago, Ill.), 1993-06, Vol.53 (12), p.2816-2822

1993

Volltextzugriff (PDF)

Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter

Cancer research (Chicago, Ill.), 1995-10, Vol.55 (19), p.4302-4310

1995

Volltextzugriff (PDF)

Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver

Cancer research (Chicago, Ill.), 1989-12, Vol.49 (23), p.6610-6614

1989

Volltextzugriff (PDF)

Conditioning : a new approach to immunotherapy

Cancer research (Chicago, Ill.), 1990-07, Vol.50 (14), p.4295-4299

1990

Volltextzugriff (PDF)

Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule

Cancer research (Chicago, Ill.), 1984-08, Vol.44 (8), p.3608-3612

1984

Volltextzugriff (PDF)

Bisantrene, an active new drug in the treatment of metastatic breast cancer

Cancer research (Chicago, Ill.), 1983-03, Vol.43 (3), p.1402-1404

1983

Volltextzugriff (PDF)

Increase of HLA-DR4 in melanoma patients from Alabama

Cancer research (Chicago, Ill.), 1982-10, Vol.42 (10), p.4276-4279

1982

Volltextzugriff (PDF)

An experimental approach to relate a tumor-associated enzyme marker to tumor cell numbers

Cancer research (Chicago, Ill.), 1977-02, Vol.37 (2), p.365

1977

Volltextzugriff (PDF)

Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humans

Cancer research (Chicago, Ill.), 1981-02, Vol.41 (2), p.459-462

1981

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieCancer Research

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(21)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

Menü

Weitere Dienste

Einstellungen

Hyperpolarized MRI Visualizes Warburg Effects and Predicts Treatment Response to mTOR Inhibitors in Patient-Derived ccRCC Xenograft Models

MYC Phosphorylation at Novel Regulatory Regions Suppresses Transforming Activity

Abstract CT055: Phase 1/2 primary analysis of ZUMA-6: Axicabtagene ciloleucel (Axi-Cel) in combination With atezolizumab (Atezo) for the treatment of patients (Pts) with refractory diffuse large B cell lymphoma (DLBCL)

The addition of adenovirus type 5 region E3 enables calydon virus 787 to eliminate distant prostate tumor xenografts

Abstract 6339: BCA101, a novel tumor-targeted bifunctional fusion antibody simultaneously inhibiting EGFR and TGF-β signaling with potential for durable tumor growth inhibition

Abstract LB-288: Differential cohort effect on early- and late-onset breast cancer incidence among Chinese women in different populations

Abstract LB-117: Myc phosphorylation suppresses transformation through novel regulatory regions

Abstract 4926: Modeling the transcriptome landscape of HER2+ breast cancer

Abstract 4975: Next generation sequencing reveals a connection between KRAS mutation and the NFkB pathway in lung adenocarcinoma samples

Abstract 3184: Whole genome sequencing of low-input fresh frozen prostate cancer biopsies

Abstract 2003: A molecular portrait of potentially curable prostate cancer

Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion

Relationship between circadian-dependent toxicity of 5-fluorodeoxyuridine and circadian rhythms of pyrimidine enzymes : possible relevance to fluoropyrimidine chemotherapy

Transformation of astrocytes in transgenic mice expressing SV40 T antigen under the transcriptional control of the glial fibrillary acidic protein promoter

Circadian variation of 5-fluorouracil catabolism in isolated perfused rat liver

Conditioning : a new approach to immunotherapy

Phase I study of tricyclic nucleoside phosphate using a five-day continuous infusion schedule

Bisantrene, an active new drug in the treatment of metastatic breast cancer

Increase of HLA-DR4 in melanoma patients from Alabama

An experimental approach to relate a tumor-associated enzyme marker to tumor cell numbers

Penetration of methylglyoxal bis(guanylhydrazone) into intracerebral tumors in humans

Aktive Filter

Suchergebnisse filtern